
HIV Essentials 2010
.
Jones and Bartlett Publishers, Inc
3rd Edition
Published on 9. October 2009
Book
Paperback/Softback
252 pages
978-0-7637-7709-8 (ISBN)
Article exhausted; check for reprint
Description
The World's Leading Experts Provide all the 'Essentials' Needed to Manage Patients in the Office, on the Ward, and in the Intensive Care Unit! HIV Essentials 2010 incorporates the latest clinical guidelines into a step-by-step guide to the diagnosis, evaluation, management and prevention of HIV infection and its complications.
More details
Edition
3rd edition
Language
English
Place of publication
Sudbury
United States
Target group
Professional and scholarly
Weight
198 gr
ISBN-13
978-0-7637-7709-8 (9780763777098)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
New editions

Paul E. Sax | Calvin J. Cohen | Daniel R. Kuritzkes
HIV Essentials 2012
Book
01/2012
5th Edition
Jones and Bartlett Publishers, Inc
€38.59
Article is exhausted; no reprint
Previous edition

Book
08/2008
2nd Edition
Jones and Bartlett Publishers, Inc
€52.23
Article exhausted; check for reprint
Persons
Dr. Paul E. Sax is Clinical Director of the Division of Infectious Diseases at Brigham and Women's Hospital (BWH), where he holds the Bruce A. Beal and Robert L. Beal Distinguished Chair in Infectious Diseases, and Professor of Medicine at Harvard Medical School. Dr. Sax received his MD from Harvard Medical School, completed his residency in Internal Medicine at BWH, then fellowship in Infectious Diseases at Massachusetts General Hospital. He is Editor-in-Chief of Clinical Infectious Diseases, the flagship journal of the Infectious Diseases Society of America, and is Section Editor of HIV/AIDS in UpToDate. He writes HIV and ID Observations for NEJM Journal Watch, and is on the Antiretroviral Guidelines Panel of the International Antiviral Society - USA. Dr. Sax teaches regularly on HIV and infectious diseases locally, nationally, and internationally. In addition to his clinical practice, writing, and teaching, his ongoing areas of research include clinical trials of antiretroviral therapies, cost-effectiveness of management strategies for HIV, and toxicity of antiretroviral therapy.